Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-06-06
2006-06-06
Zara, Jane (Department: 1635)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C536S023100, C536S023500, C536S024310
Reexamination Certificate
active
07056662
ABSTRACT:
The invention provides compositions and methods of inhibiting Mal1 expression or function to treat lipid metabolisms disorders.
REFERENCES:
patent: WO 00/47734 (2000-08-01), None
R. E. Pratley et al., The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus, DIABETOLOGIA (2001) 44: pp. 929-945.
Kane, C.D., et al., Expression, Purification, and Ligand-Binding Analysis of Recombinant Keratinocyte Lipid-Binding Protein (MAL-1), and Intracellular Lipid-Binding Protein Found Overexpressed in Neoplastic Skin Cells,Biochemistry, vol. 35, No. 9, pps. 2894-2900, 1996.
Hertzel A.V., et al., Cloning and Chromosomal Location of the MurineKeratinnocyte Lipid-Binging ProteinGene,Gene, vol. 221 (2), pp. 235-243, 1998.
Crooke, “Therapeutic Application of Oligonucleotides,” Annu. Rev. Pharmacol. Toxicol. 32,329-346, 1992.
Dolnick, “Antisense Agents in Pharmacology,” Biochem. Pharmacol. 40:671-675, 1990.
Genbank™ Accession No. AFO61015.
Genbank™ Accession No. M94856.
Hertzel et al., “Cloning and chromosomal location of the murine keratinocyte lipid-binding protein gene,” Gene, 221(2):253-43. (1998).
Hotamisligil et al., “Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein,” Science, 274(5291) pp. 1377-1379 (1996).
Kane et al., “Expression, Purification, and Ligand-binding Analysis of Recombinant Keratinocyte Lipid-binding Protein (mal-I), an Intracellular Lipid-binding Protein Found Overexpressed in neoplastic Skin Cells,” Biochemistry, 35(9): 2898-2900. 1996.
Le Doan et al., “Antisense Oligonucleotides as Potential Antiviral and Anticancer Agents,” Bull. Cancer 76:849-852, 1989.
Melani et al., “Inhibition of Proliferation by-c-mybAntisense Oligodeoxynucleotides in Colon Adenocarcinoma Cell Lines That Express c-myb,” 1991, Cancer Res. 51:2897-2901.
Scheja et al., “The adipocyte fatty acid-binding protein (aP2) as a cofactor of lipolysis in cultured adipocytes and in vivo,” Diabetes, vol. 48 No. Suppl. 1, pp. A259-A260. (1990).
Shaughnessy et al., “Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding; functional compensation by keratinocyte! fatty acid binding protein,” Diabetes, 49(6):904-11. (May. 2000).
Beattie Ingrid A.
Mintz Levin
President and Fellows of Harvard College
Zara Jane
LandOfFree
Method of diagnosing a risk of developing insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing a risk of developing insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing a risk of developing insulin resistance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3643276